Literature DB >> 2986517

Allelism in the HLA class I multigene family.

R Sodoyer, C Nguyen, T Strachan, M J Santoni, M Damotte, J Trucy, B R Jordan.   

Abstract

Recent data on the structure of functional HLA class I genes shows that, at least at the HLA-A locus, the allelic genes are more related to each other than to HLA genes from other loci. This "A-ness" is discernible at the protein sequence level but much more evident when nucleotide sequences are compared; the homology is particularly striking in the 3' non-coding region. Genes coding for the same HLA specificity in different genetic backgrounds show no obvious difference, although in one case the 3' flanking regions are clearly different; the restriction maps around the HLA-A3 and HLA-AW24 genes are also compared to see whether the chromosomal environments of these two genes are recognizably similar.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986517     DOI: 10.1016/s0769-2625(85)80040-4

Source DB:  PubMed          Journal:  Ann Inst Pasteur Immunol (1985)


  4 in total

1.  Use of RecA protein to enrich for homologous genes in a genomic library.

Authors:  B Taidi-Laskowski; D Tyan; S M Honigberg; C R Radding; F C Grumet
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

2.  An HLA-C-specific DNA probe.

Authors:  T Strachan; A B Dodge; D Smillie; P A Dyer; R Sodoyer; B R Jordan; R Harris
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Polymorphism in mouse and human class I H-2 and HLA genes is not the result of random independent point mutations.

Authors:  C Jaulin; A Perrin; J P Abastado; B Dumas; J Papamatheakis; P Kourilsky
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.